Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Malignant Lymphoma

Free Subscription Articles published in Haematologica Retrieve available abstracts of 70 articles: HTML format Text format

Single Articles

February 2012
1. JARDIN F
   Classification of diffuse large B-cell lymphoma by immunohistochemistry demonstrates that elderly patients are more common in the non-GC subgroup and younger patients in the GC subgroup (Reply).
   Haematologica. 2012;97:e4.
   PubMed     Text format     Related articles   
   
   
   
   
2. THUNBERG U , Enblad G, Berglund M
   Classification of diffuse large B-cell lymphoma by immunohistochemistry demonstrates that elderly patients are more common in the non-GC subgroup and younger patients in the GC subgroup.
   Haematologica. 2012;97:e3.
   PubMed     Text format     Related articles   
   
   
   
   January 2012
3. PERSKY DO , Dornan D, Goldman B, Braziel R, et al
   Fc gamma receptor 3a genotype predicts overall survival in follicular lymphoma patients treated on SWOG trials with combined monoclonal antibody plus chemotherapy but not chemotherapy alone.
   Haematologica. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
4. DEVILLIER R , Coso D, Castagna L, Brenot Rossi I, et al
   Positron emission tomography response at time of autologous stem cell transplantation predict outcome of patients with relapsed and/or refractory Hodgkin Lymphoma responding to prior salvage therapy.
   Haematologica. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
5. UDDIN S , Hussain AR, Ahmed M, Siddiqui K, et al
   Over-expression of FoxM1 offers a promising therapeutic target in diffuse large B-cell lymphoma.
   Haematologica. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   December 2011
6. BI Y , Zeng N, Chanudet E, Huang Y, et al
   A20 inactivation in ocular adnexal MALT lymphoma.
   Haematologica. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
7. EL-GALALY T , Mylam KJ, Brown P, Specht L, et al
   PET/CT surveillance in patients with Hodgkin lymphoma in first remission is associated with low positive predictive value and high costs.
   Haematologica. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
8. VILLA D , Seshadri T, Puig N, Massey C, et al
   Second line salvage chemotherapy for transplant-eligible patients with Hodgkin lymphoma resistant to platinum-containing first-line salvage chemotherapy.
   Haematologica. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
9. XU C , Plattel W, van den Berg A, Ruther N, et al
   Expression of the c-Met oncogene by tumor cells predicts favorable outcome in classical Hodgkin lymphoma.
   Haematologica. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
10. JONAK C , Troch M, Kiesewetter B, Lukas J, et al
    Subcutaneous dissemination pattern in extranodal marginal zone B-cell lymphoma of the mucosa associated lymphoid tissue (MALT-lymphoma).
    Haematologica. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
11. WILSON W , Jung SH, Porcu P, Hurd D, et al
    A cancer and leukemia group B multi-center study of DA-EPOCH-rituximab in untreated diffuse large B-cell lymphoma with analysis of outcome by molecular subtype.
    Haematologica. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2011
12. WANG W , Corrigan-Cummins M, Hudson J, Maric I, et al
    MicroRNA profiling of follicular lymphoma identifies microRNAs related to cell proliferation and tumor response.
    Haematologica. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
13. LIU H , Johnson JL, Koval G, Malnassy G, et al
    Detection of minimal residual disease following inductionimmunochemotherapy predicts progression free survival inmantle cell lymphoma: final results of CALGB 59909.
    Haematologica. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
14. PLATTEL WJ , van den Berg A, Visser L, van der Graaf AM, et al
    Plasma thymus and activation-regulated chemokine as an earlyresponse marker in classical Hodgkin lymphoma.
    Haematologica. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
15. BAENS M , Finalet Ferreiro J, Tousseyn T, Urbankova H, et al
    t(X;14)(p11.4;q32.33) is recurrent in marginal zone lymphoma and upregulates GPR34.
    Haematologica. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
16. CARVAJAL-CUENCA A , Sua LF, Silva NM, Pittaluga S, et al
    In situ mantle cell lymphoma: clinical implications of an incidental finding with indolent clinical behavior.
    Haematologica. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
17. ZAJA F , De Luca S, Vitolo U, Orsucci L, et al
    Salvage treatment with lenalidomide and dexamethasone in relapsed/refractory mantle cell lymphoma: clinical results and effects on microenvironment and neoangiogenic biomarkers.
    Haematologica. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2011
18. PORRATA LF , Ristow K, Colgan J, Habermann T, et al
    Peripheral blood lymphocyte/monocyte ratio at diagnosis and survival in classical Hodgkin lymphoma.
    Haematologica. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
19. SUREDA A , Canals C, Arranz R, Caballero D, et al
    Allogeneic stem cell transplantation after reduced intensityconditioning in patients with relapsed or refractory Hodgkin'slymphoma. Results of the HDR-ALLO study - a prospectiveclinical trial by the Grupo Espanol de Linfomas/ Trasplante deMedula Osea
    Haematologica. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2011
20. JACQUEMIN G , Granci V, Gallouet AS, Lalaoui N, et al
    Quercetin-mediated Mcl-1 and survivin downregulation restores TRAIL-induced apoptosis in non-hodgkin lymphoma B-cells.
    Haematologica. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
21. HARRIS NL , Kluin P
    Follicular lymphoma grade 3B: is it a real disease?
    Haematologica. 2011;96:1244-6.
    PubMed     Text format     Related articles   
    
    
    
    
22. NAKAGAWA M , Tsuzuki S, Honma K, Taguchi O, et al
    Synergistic effect of Bcl2, Myc and Ccnd1 transforms mouse primary B cells into malignant cells.
    Haematologica. 2011;96:1318-26.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2011
23. ASANO N , Kinoshita T, Tamaru JI, Ohshima K, et al
    Cytotoxic molecule-positive classical Hodgkin lymphoma: a clinicopathologic comparison with cytotoxic molecule-positive peripheral T-cell lymphoma of not otherwise specified type.
    Haematologica. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
24. MARESCHAL S , Lanic H, Ruminy P, Bastard C, et al
    The proportion of activated B-cell like subtype among de novo diffuse large B-cell lymphoma increases with age.
    Haematologica. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
25. HAREL S , Ferme C, Poirot C
    Management of fertility in patients treated for Hodgkin lymphoma.
    Haematologica. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
26. FURTADO M , Rule S
    Indolent mantle cell lymphoma.
    Haematologica. 2011;96:1086-8.
    PubMed     Text format     Related articles   
    
    
    
    
27. ONDREJKA SL , Lai R, Smith SD, Hsi ED, et al
    Indolent mantle cell leukemia: a clinicopathological variant characterized by isolated lymphocytosis, interstitial bone marrow involvement, kappa light chain restriction, and good prognosis.
    Haematologica. 2011;96:1121-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2011
28. KLEPPE M , Tousseyn T, Geissinger E, Kalender Atak Z, et al
    Mutation analysis of the tyrosine phosphatase PTPN2 in Hodgkin lymphoma and T-cell non-Hodgkin lymphoma.
    Haematologica. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
29. KWEE I , Rancoita PM, Rinaldi A, Ferreri AJ, et al
    Genomic profiles of MALT lymphomas: variability across anatomical sites.
    Haematologica. 2011;96:1064-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2011
30. HORN H , Schmelter C, Leich E, Salaverria I, et al
    Follicular lymphoma grade 3b is a distinct neoplasm according to cytogenetic and immunohistochemical profiles.
    Haematologica. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2011
31. GIBSON SE , Swerdlow SH, Ferry JA, Surti U, et al
    Reassessment of small lymphocytic lymphoma in the era of monoclonal B-cell lymphocytosis.
    Haematologica. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
32. CARDESA-SALZMANN TM , Colomo L, Gutierrez G, Chan WC, et al
    High microvessel density determines a poor outcome in patients with diffuse large B-cell lymphoma treated with rituximab plus chemotherapy.
    Haematologica. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
33. FITOUSSI O , Belhadj K, Mounier N, Parrens M, et al
    Survival impact of rituximab combined with ACVBP and upfront consolidative autotransplantation in high risk diffuse large B-cell lymphoma for GELA.
    Haematologica. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
34. MARCOS-GRAGERA R , Allemani C, Tereanu C, De Angelis R, et al
    Survival of European patients diagnosed with lymphoid neoplasms in 2000-2002: results of the HAEMACARE project.
    Haematologica. 2011;96:720-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    April 2011
35. VILLA D , Connors JM, Sehn LH, Gascoyne RD, et al
    Diffuse large B-cell lymphoma with involvement of the kidney: outcome and risk of central nervous system relapse.
    Haematologica. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
36. LAMM W , Kaufmann H, Raderer M, Hoffmann M, et al
    Bortezomib combined with rituximab and dexamethasone is an active regimen for patients with relapsed and chemotherapy-refractory mantle cell lymphoma.
    Haematologica. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
37. LE GOUILL S , De Guibert S, Planche L, Brice P, et al
    Impact of the use of autologous stem cell transplantation at first relapse both in naive and previously rituximab exposed follicular lymphoma patients treated in the GELA/GOELAMS FL2000 study.
    Haematologica. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
38. JACOBS G , Hellmig S, Huse K, Titz A, et al
    Polymorphisms in the 3'UTR of the CDH1 gene are a risk factor for primary gastric diffuse large B-cell lymphoma.
    Haematologica. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
39. EBERLE FC , Rodriguez-Canales J, Wei L, Hanson JC, et al
    Methylation profiling of mediastinal gray zone lymphoma reveals a distinctive signature with elements shared by classical Hodgkin's lymphoma and primary mediastinal large B-cell lymphoma.
    Haematologica. 2011;96:558-66.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
40. QUINTANILLA-MARTINEZ L , Fend F
    Mediastinal gray zone lymphoma.
    Haematologica. 2011;96:496-9.
    PubMed     Text format     Related articles   
    
    
    
    March 2011
41. SEITZ V , Thomas PE, Zimmermann K, Paul U, et al
    Classical Hodgkin lymphoma shows epigenetic features of an abortive plasma cellular differentiation.
    Haematologica. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
42. RUMI E , Passamonti F, Elena C, Pietra D, et al
    Increased risk of lymphoid neoplasm in patients with myeloproliferative neoplasm: a study of 1,915 patients.
    Haematologica. 2011;96:454-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
43. STEPENSKY P , Weintraub M, Yanir A, Revel-Vilk S, et al
    IL-2-inducible T-cell kinase deficiency: clinical presentation and therapeutic approach.
    Haematologica. 2011;96:472-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2011
44. WANG L , Shi WY, Yang F, Tang W, et al
    Bevacizumab potentiates chemotherapeutic effect on T-leukemia/lymphoma cells by direct action on tumor endothelial cells.
    Haematologica. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
45. WASAG B , Lierman E, Meeus P, Cools J, et al
    The kinase inhibitor TKI258 is active against the novel CUX1-FGFR1 fusion detected in a patient with T-lymphoblastic leukemia/lymphoma and t(7;8)(q22;p11).
    Haematologica. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
46. VISHWAMITRA D , Shi P, Wilson D, Manshouri R, et al
    Expression and effects of inhibition of IGF-IR tyrosine kinase in mantle cell lymphoma.
    Haematologica. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
47. STEIDL C , Farinha P, Gascoyne RD
    Macrophages predict treatment outcome in Hodgkin's lymphoma.
    Haematologica. 2011;96:186-9.
    PubMed     Text format     Related articles   
    
    
    
    
48. BEDWELL C , Rowe D, Moulton D, Jones G, et al
    Cytogenetically complex SEC31A-ALK fusions are recurrent in ALK-positive large B-cell lymphomas.
    Haematologica. 2011;96:343-6.
    PubMed     Text format     Related articles   
    
    
    
    
49. OSCHLIES I , Burkhardt B, Salaverria I, Rosenwald A, et al
    Clinical, pathological and genetic features of primary mediastinal large B-cell lymphomas and mediastinal gray zone lymphomas in children.
    Haematologica. 2011;96:262-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2011
50. SASAKI D , Imaizumi Y, Hasegawa H, Osaka A, et al
    Overexpression of enhancer of zeste homolog 2 with trimethylation of lysine 27 on histone H3 in adult T-cell leukemia/lymphoma as a target for epigenetic therapy.
    Haematologica. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    December 2010
51. NEGREA OG , Elstrom R, Allen SL, Rai KR, et al
    Subcutaneous injections of low-dose veltuzumab (humanized anti-CD20 antibody) are safe and active in patients with indolent non-Hodgkin lymphoma.
    Haematologica. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
52. TAKEUCHI K , Soda M, Togashi Y, Ota Y, et al
    Identification of a novel fusion, SQSTM1-ALK, in ALK-positive large B-cell lymphoma.
    Haematologica. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
53. WATKINS AJ , Hamoudi R, Liu H, Zhang J, et al
    Retraction. Characterisation of 7q32 deletion of splenic marginal zone lymphoma demonstrates frequent miR-182 somatic mutations in a wide range of lymphoma subtypes.
    Haematologica. 2010;95:2166.
    PubMed     Text format     Related articles   
    
    
    
    November 2010
54. BRAZA MS , Klein B, Fiol G, Rossi JF, et al
    {gamma}{delta} T cells killing of primary follicular lymphoma cells is dramatically potentiated by GA101, a type II glycoengineered anti-CD20 monoclonal antibody.
    Haematologica. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
55. KAMPER P , Bendix K, Hamilton-Dutoit S, Honore' B, et al
    Tumor-infiltrating macrophages correlate with adverse prognosis and Epstein-Barr virus status in classical Hodgkin lymphoma.
    Haematologica. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
56. SCALA E , Abeni D, Pomponi D, Narducci MG, et al
    The role of 9-O-acetylated ganglioside D3 (CD60) and {alpha}4{beta}1 (CD49d) expression in predicting the survival of patients with Sezary syndrome.
    Haematologica. 2010;95:1905-12.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2010
57. ANAND M , Lai R, Gelebart P
    Beta-catenin is constitutively active and increases STAT3 expression/activation in ALK-positive anaplastic large cell lymphoma.
    Haematologica. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
58. GOEKBUGET N , Hartog CM, Bassan R, Derigs HG, et al
    Liposomal cytarabine is effective and tolerable in the treatment of CNS relapse of acute lymphoblastic leukemia (ALL) and very aggressive lymphoma.
    Haematologica. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
59. GEISSINGER E , Sadler P, Roth S, Grieb T, et al
    Disturbed expression of the T-cell receptor/CD3 complex and associated signaling molecules in CD30+ T-cell lymphoproliferations.
    Haematologica. 2010;95:1697-704.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2010
60. WATKINS AJ , Hamoudi R, Liu H, Zhang J, et al
    Characterisation of 7q32 deletion of splenic marginal zone lymphoma demonstrates frequent miR-182 somatic mutations in a wide range of lymphoma subtypes.
    Haematologica. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
61. AIT-TAHAR K , Liggins AP, Collins GP, Campbell A, et al
    CD4-positive Th responses to the PASD1 protein in patients with diffuse large B-cell lymphoma.
    Haematologica. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
62. GUFFEI A , Sarkar R, Klewes L, Righolt C, et al
    Dynamic chromosomal rearrangements in Hodgkin's lymphoma are due to ongoing 3D nuclear remodeling and breakage-bridge-fusion cycles.
    Haematologica. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
63. SCHOLTYSIK R , Kreuz M, Klapper W, Burkhardt B, et al
    Detection of genomic aberrations in molecularly defined Burkitt lymphoma by array-based high resolution single nucleotide polymorphism analysis.
    Haematologica. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2010
64. THOMPSON PA , Lade S, Webster H, Ryan G, et al
    Effusion-associated anaplastic large cell lymphoma of the breast: time for it to be defined as a distinct clinico-pathological entity.
    Haematologica. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
65. FARINHA P , Kyle A, Minchinton A, Connors J, et al
    Vascularization predicts overall survival and risk of transformation in follicular lymphoma.
    Haematologica. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
66. GEISLER CH
    Front-line treatment of mantle cell lymphoma.
    Haematologica. 2010;95:1241-3.
    PubMed     Text format     Related articles   
    
    
    
    
67. GOMES AQ , Correia DV, Grosso AR, Lanca T, et al
    Identification of a panel of ten cell surface protein antigens associated with immunotargeting of leukemias and lymphomas by peripheral blood gammadelta T cells.
    Haematologica. 2010;95:1397-404.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2010
68. BARAN-MARSZAK F , Boukhiar M, Harel S, Laguillier C, et al
    Constitutive and B-cell receptor-induced activation of STAT3 are important signaling pathways targeted by bortezomib in leukemic mantle cell lymphoma.
    Haematologica. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    April 2010
69. DUFOUR C , Cappelli B, Calvillo M, Fioredda F, et al
    Similar favorable outcome of pegfilgrastim overdose in patients with different age and underlying disease.
    Haematologica. 2010;95:684-5.
    PubMed     Text format     Related articles   
    
    
    
    
70. BASEGGIO L , Traverse-Glehen A, Petinataud F, Callet-Bauchu E, et al
    CD5 expression identifies a subset of splenic marginal zone lymphomas with higher lymphocytosis: a clinico-pathological, cytogenetic and molecular study of 24 cases.
    Haematologica. 2010;95:604-12.
    PubMed     Text format     Related articles    Abstract available
    
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: